This inventor holds 2 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1976-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Naruto, JA (1976)
- Naruto, JP (1980)
Company Filing History:
Years Active: 1976-1980
Title: Takashi Suzue: Innovator in Pharmaceutical Chemistry
Introduction
Takashi Suzue is a prominent inventor based in Naruto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative oral antilipemic agents and N-substituted guanidino acid derivatives. With a total of 2 patents, his work has garnered attention for its potential therapeutic applications.
Latest Patents
One of his latest patents focuses on oral antilipemic agents. This invention comprises a pharmaceutically effective amount of at least one acidic polyamino acid with a molecular weight ranging from 10,000 to 100,000, along with pharmaceutically acceptable salts and an adjuvant. Another notable patent involves N-substituted guanidino acid derivatives, which are characterized by a specific chemical formula. These compounds exhibit excellent pharmacological activities, particularly in antagonizing bradykinin and histamine, making them useful as anti-inflammatory agents.
Career Highlights
Takashi Suzue is currently associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address various health issues.
Collaborations
Throughout his career, Takashi has collaborated with notable colleagues, including Motoyoshi Kajihara and Toshihiro Hamakawa. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
In summary, Takashi Suzue is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His innovative patents reflect his commitment to improving health outcomes through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
